| 前收市價 | 6.46 |
| 開市 | 6.40 |
| 買盤 | 6.28 x 400 |
| 賣出價 | 6.33 x 100 |
| 今日波幅 | 6.30 - 6.41 |
| 52 週波幅 | 3.06 - 6.76 |
| 成交量 | |
| 平均成交量 | 2,528,832 |
| 市值 | 1.465B |
| Beta 值 (5 年，每月) | 0.43 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.13 |
| 業績公佈日 | 2024年5月08日 - 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 8.38 |
ZacksRecent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why
Adma Biologics (ADMA) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
ZacksAdma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note
In the most recent trading session, Adma Biologics (ADMA) closed at $6.27, indicating a +1.13% shift from the previous trading day.
ZacksSage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
Data from a mid-stage study show that Sage's (SAGE) experimental oral drug failed to show a statistically significant difference in treating patients with Parkinson's disease compared with a placebo.
